Letters to the Editor

Clonality analysis of HTLV-1-infected cells enhances prognostic precision in smoldering adult T-cell leukemia/lymphoma

Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan; Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa
Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa, Japan; Department of Neurology, St. Marianna University School of Medicine, Kanagawa
Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki
Pathophysiology and Bioregulation, St. Marianna University Graduate School of Medicine, Kanagawa
Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo
Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa
Medical Scientist Training Program, Washington University School of Medicine, St. Louis, MO, United States
Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo
Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki
Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa
Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa
Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa
Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo
Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki
Japanese Red Cross Kyushu Block Blood Center, Fukuoka
Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan; Department of Hematology/Oncology, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo
Imamura General Hospital, Kagoshima
Department of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka
Department of Hematology, Nagasaki University Hospital, Nagasaki
Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki
Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan; Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki
Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki
Department of Hematology and Oncology, St. Marianna University Graduate School of Medicine, Kanagawa
Department of Hematology and Oncology, St. Marianna University Graduate School of Medicine, Kanagawa
Department of Hematology and Oncology, St. Marianna University Graduate School of Medicine, Kanagawa
Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa, Japan; Department of Neurology, St. Marianna University School of Medicine, Kanagawa
Haematologica Early view Apr 30, 2025 https://doi.org/10.3324/haematol.2025.287521